Abstract
BackgroundEvidence suggests that patients (pts) with moderate rheumatoid arthritis (RA) despite DMARDs gain benefit from anti-TNF therapy; however, to be eligible for reimbursement, pts often require severe disease activity to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
